0000000000652312

AUTHOR

Giuseppe Barbaro

showing 9 related works from this author

Chronic pharmacological treatment in takotsubo cardiomyopathy.

2008

Abstract Background Takotsubo cardiomyopathy is a disorder that has been appreciated only recently. In most of reported cases, this syndrome mimes an acute myocardial infarction. Till this moment no data are available from literature about the treatment in the acute phase of this disease. Aim of the study In our multicentric experience we have retrospectively looked at the benefits of a treatment with ACE-inhibitors, beta-blockers, Aspirin and calcium channels blockers, started until the early phases of the disease and continued for 30 days, in 36 patients affected by Takotsubo cardiomyopathy. We chose as endpoint of the study the efficacy of the used drug in improving left ventricular myoc…

Malemedicine.medical_specialtyHeart diseaseAdrenergic beta-AntagonistsCardiomyopathyAngiotensin-Converting Enzyme InhibitorsTakotsubo CardiomyopathyInternal medicineMedicineHumansMyocardial infarctionAgedRetrospective StudiesAspirinEjection fractionAspirinbusiness.industryRetrospective cohort studymedicine.diseaseCalcium Channel BlockersSurgeryTreatment OutcomeACE inhibitorCardiologyFemaleDifferential diagnosisCardiology and Cardiovascular Medicinebusinessmedicine.drugInternational journal of cardiology
researchProduct

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

2008

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, …

medicine.medical_specialtyHeart diseasemedicine.medical_treatmentAdrenergic beta-AntagonistsElectric CountershockPHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.Catheter ablationElectrocardiographyPharmacotherapyInternal medicineAtrial FibrillationDrug DiscoverymedicineHumanscardiovascular diseasesChildUltrasonographyPharmacologyFibrillationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Cardiac Pacing ArtificialAtrial fibrillationCalcium Channel Blockersmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareAtrial fibrillation atrial flutter pharmacological therapy childrenAtrial FlutterChronic DiseaseCatheter Ablationcardiovascular systemCardiologymedicine.symptombusinessAnti-Arrhythmia AgentsElectrocardiographyAtrial flutterCurrent Pharmaceutical Design
researchProduct

Tako-tsubo cardiomyopathy and microcirculation.

2010

Takotsubo cardiomyopathy was described for the first time in Japan in the 1990s. It is very similar to the ischemic cardiopathy both for clinical and instrumental characteristics. His peculiarity is an alteration of the ventricular contraction mechanism with hypo-akinesis of the apex and lateral segments of the left ventricle, associated with hyper-kinesis of the heart base which is responsible for the typical echocardiographic aspect of a cruet during the systole. However, the etiology of this cardiomyopathy is still unknown despite the fact that numerous hypothesis have been made. A single study of 16 patients proved multivasal damage by a BLASH SCORE analysis of the coronary radiography.…

Malemedicine.medical_specialtytako-tsubo cardiomyopathyCardiomyopathycoronary microcirculation; takotsubo; timi frame countHemodynamicsHealth InformaticsAnterior Descending Coronary ArteryCritical Care and Intensive Care MedicineCoronary AngiographyMicrocirculationTakotsubo CardiomyopathyInternal medicinemedicine.arteryCoronary CirculationMedicineHumansAgedbusiness.industryMicrocirculationmedicine.diseaseStenosisAnesthesiology and Pain Medicinemedicine.anatomical_structureRight coronary arteryCardiologyRadiographic Image Interpretation Computer-AssistedFemalebusinessTIMIBlood Flow VelocityArteryJournal of clinical monitoring and computing
researchProduct

The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndrome.

2008

Heart Failure (CHF) is a very important public health problem in the world and certainly one of the most common debilitating diseases and cause of mortality. Current knowledge underlines that incidence rates are also influenced by the coexisting pathologic conditions that accelerate the development of disease or increase its severity. Important scientific evidence is emerging to demonstrate a strong correlation between HF and the metabolic syndrome (MetS). Hypolipemia- inducing medication offers the opportunity to discuss the possible existence of pharmacological substances that in addition to their specific targets have several demonstrated pleiotropic effects that could be beneficial in H…

medicine.medical_specialtyHeart diseaseDiseaseBioinformaticsstatin congestive heart failure metabolic sydromeHypolipemiaInternal medicineDrug DiscoverymedicineAnimalsHumansIn patientPharmacologyHeart FailureMetabolic SyndromeClinical Trials as Topicbusiness.industryPublic healthmedicine.diseaseOxidative StressEndocrinologyHeart failureDisease ProgressionMetabolic syndromeHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCurrent pharmaceutical design
researchProduct

Treatment of Tako-tsubo cardiomyopathy

2008

N.A.

medicine.medical_specialtyCardiotonic AgentsHeart diseasebusiness.industryCardiomyopathyTako-tsubo Cardiomyopathymedicine.diseaseTako-tsubo cardiomyopathyTakotsubo CardiomyopathyInternal medicinePractice Guidelines as TopicACE inhibitormedicineCardiologyHumansMyocardial diseaseCardiology and Cardiovascular MedicinebusinessBeta (finance)medicine.drugInternational Journal of Cardiology
researchProduct

Transient mid-ventricular dyskinesia: a variant of Takotsubo syndrome

2008

Takotsubo Cardiomyopathy is characterized by a reversible systolic left ventricular apical ballooning. A new pattern of dyskinesia in the absence of angiographic evidence of coronary artery stenosis has been indicated like a variant of takotsubo cardiomiopathy: mid-ventricular akinesis with preservation of apical and basal contractilities revealed at echocardiograms and ventriculographies. We report the case of a 65 years old patient with this pattern, reverted in 4 weeks.

medicine.medical_specialtyTakotsubo syndromeTakotsubo Cardiomyopathy Mid-ventricular dyskinesia Echocardiograms VentriculographiesHeart diseasebusiness.industryCardiomyopathyNeurological disordermedicine.diseaseVentricular dyskinesiaSurgeryCentral nervous system diseaseBasal (phylogenetics)DyskinesiaInternal medicinecardiovascular systemCardiologyMedicinecardiovascular diseasesmedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Patent Foramen Ovale and Thromboembolic Complications

2010

The foramen ovale, an atrial septal defect which is essential in the fetal circulation, remains patent through adulthood in approximately 25% of the general population and so it represents the most common persistent abnormality of fetal origin. Patent foramen ovale (PFO) allows interatrial right-to-left blood shunting during those periods of the cardiac cycle in which the right atrial pressure exceeds the left one. An increasing number of pathological manifestations of PFO has been recently identified; among these, paradoxical systemic embolism, refractory hypoxemia in patients with right ventricular myocardium infarction or severe pulmonary disease, orthostatic oxygen desaturation in the r…

medicine.medical_specialtyMagnetic Resonance SpectroscopyPopulationEchocardiography Three-DimensionalForamen secundumForamen Ovale PatentPersistent fetal circulationHypoxemiaPFOThromboembolismDrug DiscoverymedicineHumanseducationForamen ovale (heart)Pharmacologyeducation.field_of_studybusiness.industrySettore MED/23 - Chirurgia Cardiacamedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisSurgerymedicine.anatomical_structureEmbolismEchocardiographyPatent foramen ovalemedicine.symptomTomography X-Ray ComputedbusinessEchocardiography TransesophagealCurrent Pharmaceutical Design
researchProduct

Clinical findings of Takotsubo cardiomyopathy: results from a multicenter international study

2008

BACKGROUND: Takotsubo cardiomyopathy consists of reversible systolic left ventricular apical ballooning associated with chest pain. Electrocardiographic abnormalities and the minimal rise of serum cardiac markers are similar to those in acute myocardial infarction, but without evidence of myocardial ischemia or injury. To date, many reports concerning this kind of acute reversible heart failure have been published, but the information available about the management of affected patients is scarce and the clinical data are incomplete. AIMS: In the present study, we report a collection of 40 patients who were affected by Takotsubo cardiomyopathy obtained in a multicentric international study, …

Malemedicine.medical_specialtyTime FactorsCardiomyopathyChest painCoronary AngiographySeverity of Illness IndexTakotsubo cardiomiopathyDiagnosis DifferentialElectrocardiographyTakotsubo CardiomyopathyInternal medicineSeverity of illnessmedicineHumanscardiovascular diseasesMyocardial infarctionAgedmedicine.diagnostic_testbusiness.industryclinical and instrumental patternGated Blood-Pool ImagingStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisMyocardial ContractionSettore MED/11 - Malattie Dell'Apparato CardiovascolareGated Blood-Pool ImagingEchocardiographynatural historydiagnostic criteriacardiovascular systemCardiologyExercise TestFemaleDifferential diagnosismedicine.symptomCardiology and Cardiovascular MedicinebusinessElectrocardiographymanagementFollow-Up Studies
researchProduct

Editorial: Current trends in the treatment of supraventricular tachycardia in pediatric age

2008

In pediatric age supraventricular tachiarrhythmias represent one of the most common cause of admission in cardiology units. Supraventricular arrhythmias may significantly influence the normal growth of a child with significant psycho-social implications. Pediatric cardiologists should be aware about the arrhythmias they face in their clinical practice. Moreover, they should know the possible risks related to specific arrhythmias and use the most efficacious therapeutic strategy with a correct knowledge of antiarrhythmic drugs. In this issue of Current Pharmacological Design the most recent knowledges on pathophysiology, diagnosis and treatment of supraventricular tachyarrhythmias in pediatr…

Antiarrhythmic agentSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct